CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Boehringer Ingelheim against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Interleukin-31 Monoclonal AntibodyZOETIS SERVICESJun 13, 2025
Interleukin-31 Monoclonal AntibodyZOETIS SERVICESMay 20, 2025
5-(3-(Ethylsulfonyl)Pyridin-2-Yl)-Pyrazolo[1,5-A]Pyrimidine Derivatives And Related Compounds As Pesticide And Insecticide Agents For Crop ProtectionPI INDUSTRIESJan 16, 2025
Methods Of Vaccine AdministrationZOETIS SERVICESMar 13, 2024
Heterocyclic Compounds And Noxious Arthropod Control Agent Containing SameSUMITOMO CHEMICALDec 20, 2023
Recombinant Non-Pathogenic Marek'S Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus And Infectious Bursal Disease Virus AntigensINTERVETSep 12, 2023
Cell Culture Medium Comprising Small PeptidesLIFEAug 1, 2023
Carbon-Source Regulated Protein Production In A Recombinant Host CellLONZAJan 9, 2023
Mycoplasma Hyopneumoniae VaccineZOETISOct 3, 2022
Anti-Dll3 AntibodyCHUGAI SEIYAKU KABUSHIKI KAISHAMar 22, 2022

Explore Boehringer Ingelheim's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Apr 24, 2024Containers For Compositions Comprising Meloxicam1
Apr 10, 2024Pharmaceutical Composition, Pharmaceutical Dosage Form, Process For Their Preparation, Methods For Treating And Uses Thereof4
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A Patient18
Nov 22, 2023Pharmaceutical Dosage Form For Immediate Release Of An Indolinone Derivative3
Oct 25, 2023An Sglt-2 Inhibitor For Use In The Treatment Of A Metabolic Disorder In Feline Animals1
Jun 28, 2023Medical Use Of A Dpp-4 Inhibitor5
May 10, 2023Treatment Of Metabolic Disorders In Canine Animals1
Apr 26, 2023Novel Immune Checkpoint Inhibitors1
Feb 22, 2023Vaccine Against Porcine Parvovirus And Porcine Reproductive And Respiratory Syndrome Virus And Methods Of Production Thereof1
Jan 18, 2023Sglt-2 Inhibitor For Use In The Treatment Of A Metabolic Myopathy2

Top competitors of Boehringer Ingelheim

List of top competitors of Boehringer Ingelheim based on patent oppositions.